MARKET

ORGO

ORGO

Organogenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.99
-0.87
-8.01%
Pre Market: 10.01 +0.02 +0.20% 08:00 01/22 EST
OPEN
11.01
PREV CLOSE
10.86
HIGH
11.05
LOW
9.86
VOLUME
1.12K
TURNOVER
--
52 WEEK HIGH
11.13
52 WEEK LOW
2.472
MARKET CAP
1.27B
P/E (TTM)
-173.7391
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 20)
Benzinga · 1d ago
Earnings Estimates Rising for ORGANOGENESIS (ORGO): Will It Gain?
ORGANOGENESIS (ORGO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks · 1d ago
DJ Organogenesis Holdings Is Maintained at Outperform by SVB Leerink
Dow Jones · 2d ago
DJ Organogenesis Holdings Price Target Raised to $13.00/Share From $10.00 by SVB Leerink
Dow Jones · 2d ago
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14)
Benzinga · 01/15 12:57
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%
Zacks.com · 01/15 02:04
FCEL, GME, MAXR and FCAU among midday movers
Gainers: Datasea (DTSS) +90%.Lexicon Pharmaceuticals (LXRX) +85%.Pennsylvania Real Estate Investment Trust (PEI) +50%.DPW Holdings (DPW) +36%.Organogenesis (ORGO) +34%.Acacia Communications (ACIA) +33%.Bicycle Therapeutics (BCYC) +31%.AeroVironment (AVAV) +29%.Maxar Technologies (MAXR) +27%.GameStop (GME) +25%.Losers: Viveve Medical (VIVE) -21%.Volt Information
Seekingalpha · 01/14 17:42
Lexicon Pharmaceuticals and NantKwest among healthcare gainers; Cassava Sciences among losers
Gainers: Organogenesis Holdings (ORGO) +33%. Lexicon Pharmaceuticals (LXRX) +30%. NantKwest (NK) +27%. Oragenics (OGEN) +25%. Bicycle Therapeutics (BCYC) +23%.Losers: Viveve Medical (VIVE) -23%. Cassava Sciences (SAVA) -12%. Timber Pharmaceuticals (TMBR) -11%. InflaRx
Seekingalpha · 01/14 16:01
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ORGO. Analyze the recent business situations of Organogenesis Holdings Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ORGO stock price target is 12.25 with a high estimate of 14.00 and a low estimate of 9.00.
EPS
Institutional Holdings
Institutions: 67
Institutional Holdings: 5.00M
% Owned: 3.93%
Shares Outstanding: 127.37M
TypeInstitutionsShares
Increased
15
781.63K
New
13
22.83K
Decreased
20
204.73K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.30%
Pharmaceuticals & Medical Research
-0.53%
Key Executives
President/Chief Executive Officer/Director
Gary Gillheeney
Chief Financial Officer/Vice President - Finance/Treasurer
Henry Hagopian
Chief Operating Officer
Patrick Bilbo
Vice President/General Counsel
Lori Freedman
Vice President
Antonio Montecalvo
Other
Brian Grow
Director
Maurice Ades
Director
Glenn Nussdorf
Independent Director
Alan Ades
Independent Director
Albert Erani
Independent Director
Arthur Leibowitz
Independent Director
Wayne Mackie
Independent Director
Joshua Tamaroff
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ORGO
Organogenesis Holdings Inc., formerly Avista Healthcare Public Acquisition Corp, is a regenerative medicine company. The Company focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. It also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The Company is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
More

Webull offers kinds of Organogenesis Holdings Inc stock information, including NASDAQ:ORGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ORGO stock methods without spending real money on the virtual paper trading platform.